Clinical Microbiology: Gram Stains, Antibiotic Stewardship and Key Pathogens

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/201

encourage image

There's no tags or description

Looks like no tags are added yet.

202 Terms

1
New cards

Gram positive stain color and why

PURPLE. Thick peptidoglycan holds the crystal violet. Mnemonic from lecture: Gram POSITIVE has more P's (Purple, Peptidoglycan thick)

2
New cards

Gram negative stain color and why

PINK. Thin peptidoglycan layer PLUS an outer membrane made of lipopolysaccharide (LPS); crystal violet washes off

3
New cards

Gram-positive cocci in CLUSTERS

Staphylococcus

4
New cards

Gram-positive cocci in PAIRS/CHAINS

Streptococcus and Enterococcus

5
New cards

Gram-positive RODS

Listeria monocytogenes, Corynebacterium

6
New cards

Gram-positive ANAEROBES

Peptostreptococcus, Cutibacterium, Clostridium spp. (associated with dental infections; can also cause intra-abdominal infections)

7
New cards

Gram-negative COCCI

Neisseria

8
New cards

Gram-negative COCCOBACILLI

Acinetobacter baumannii, Bordetella pertussis, Moraxella catarrhalis

9
New cards

Gram-negative ANAEROBES

Bacteroides fragilis (most clinically important), Prevotella, Fusobacterium

10
New cards

Gram-negative ENTERIC rods (colonize the gut)

Proteus mirabilis, E. coli, Klebsiella, Serratia, Enterobacter cloacae, Citrobacter

11
New cards

Gram-negative rods that do NOT colonize the gut

Pseudomonas aeruginosa, Haemophilus influenzae, Providencia

12
New cards

Where do anaerobes thrive?

Low-oxygen sites: oral cavity, GI tract, deep tissues

13
New cards

Commensal vs pathogen

Commensal = normal flora that isn't necessarily causing infection; pathogen = causes disease. Depends on SITE (E. coli in the gut = normal; E. coli in blood = infection)

14
New cards

Why collect cultures BEFORE starting antibiotics?

Antibiotics can negatively affect culture growth

15
New cards

Stepwise approach to ID (in order)

1) Identify infection type and likely source (community vs healthcare-acquired; anatomical site) 2) Collect cultures FIRST 3) Empiric therapy covering likely pathogens 4) De-escalate based on culture and sensitivity 5) Duration and follow-up (response, toxicity, prophylaxis)

16
New cards

Empiric vs targeted therapy

Empiric = chosen before culture results, based on infection type/likely organisms/patient factors. Targeted = based on culture and susceptibilities

17
New cards

Stewardship: the 4 D's of de-escalation (from lecture)

Right Diagnosis (is there an infection?), Drug, Dose (renally dose!), Duration (shortest effective); then de-escalate: narrow, stop, or switch IV to PO

18
New cards

Why are antibiotics "not benign"?

Adverse effects and C. difficile, increased hospital stay and cost, selective pressure for resistance

19
New cards

Selection pressure

Antibiotics kill susceptible bacteria and leave resistant organisms behind to multiply

20
New cards

Reading a coverage chart: what do +, 0, +/- mean?

+ = generally covers; 0 = does not reliably cover; +/- = variable/partial coverage (NOT reliable). ++ sometimes marks first-line. Coverage does not equal effectiveness at every site (PK/PD and penetration matter)

21
New cards

Antibiogram: what does it show and what's the minimum?

Percent of isolates susceptible to each drug; needs at least 30 isolates to be included

22
New cards

Susceptibility report: what do S, I, SDD, R mean?

S = Susceptible (likely responds at standard dose); I = Intermediate (borderline, may work at high concentrations such as urine); SDD = Susceptible-dose dependent (needs higher-than-standard dosing); R = Resistant (do not use)

23
New cards

MIC

Minimum inhibitory concentration: lowest antibiotic concentration that visibly inhibits bacterial growth in vitro. Compare to breakpoints (set by CLSI). You CANNOT compare MICs between different bug-drug pairs

24
New cards

Susceptibility lab workflow

Culture the sample, identify the organism, determine the MIC, compare the MIC to the breakpoint, report S/I/SDD/R

25
New cards

PK/PD target: Cmax/MIC (concentration-dependent)

Aminoglycosides (higher peak = more killing; large dose with extended interval; low troughs limit toxicity)

26
New cards

PK/PD target: Time > MIC (time-dependent)

Beta-lactams (keep concentration above MIC for most of the interval: more frequent dosing, extended infusion, or continuous infusion)

27
New cards

PK/PD target: AUC/MIC

Vancomycin (has elements of both concentration- and time-dependent killing)

28
New cards

Fluoroquinolone killing pattern

Concentration-dependent (slide 57)

29
New cards

Why give piperacillin/tazobactam as a 4-hour extended infusion?

Beta-lactams exhibit TIME-dependent killing; extended infusion keeps the concentration above the MIC longer

30
New cards

HNPEK

Haemophilus, Neisseria, Proteus, E. coli, Klebsiella (the more common GNs; respiratory + urinary)

31
New cards

SPACE

Serratia, Pseudomonas, Acinetobacter, Citrobacter, Enterobacter (nosocomial GNs; more resistant than HNPEK)

32
New cards

Respiratory gram negatives

H. influenzae, Moraxella catarrhalis, Neisseria meningitidis

33
New cards

Urinary gram negatives

E. coli, Klebsiella pneumoniae, Proteus mirabilis

34
New cards

Nosocomial gram negatives

SPACE (Serratia, Pseudomonas, Acinetobacter, Citrobacter, Enterobacter)

35
New cards

Which GN group is MORE resistant: HNPEK or SPACE?

SPACE

36
New cards

Staphylococcus: where does it live?

Skin and nares

37
New cards

Coagulase-positive Staph

S. aureus ("infects pretty much everything")

38
New cards

Coagulase-negative Staph (CoNS) examples

S. epidermidis (often a contaminant; forms biofilms on devices); S. saprophyticus (UTIs in young women)

39
New cards

MS vs MR

Methicillin-susceptible vs methicillin-resistant (applies to S. aureus and CoNS)

40
New cards

Staph epidermidis

CoNS; often a contaminant; forms biofilms on devices

41
New cards

Staph saprophyticus

CoNS; causes UTIs in young women

42
New cards

Strep pyogenes

Group A, beta-hemolytic. Pharyngitis, cellulitis, necrotizing fasciitis, rheumatic fever

43
New cards

Strep agalactiae

Group B, beta-hemolytic. Neonatal sepsis, obstetric infections

44
New cards

Strep anginosus

Abscesses

45
New cards

Strep pneumoniae

Meningitis, otitis media, pneumonia, sinusitis

46
New cards

Viridans group strep (mitis, mutans)

Endocarditis after dental procedures

47
New cards

Beta-hemolytic strep are named by...

Groups with letters: Group A (pyogenes) and Group B (agalactiae). Beta-hemolysis = complete lysis of red blood cells on blood agar

48
New cards

Enterococcus: where does it live and what does it cause?

Lives in the GI tract; causes UTI, endocarditis, biliary tree infections

49
New cards

E. faecalis vs E. faecium

faecalis = more common, LESS resistant. faecium = less common, MORE resistant (hospital; often VRE)

50
New cards

VRE

Vancomycin-resistant Enterococcus (usually E. faecium)

51
New cards

Gram-positive group that NO cephalosporin covers

Enterococcus (lecture: NO Enterococcus coverage!!!)

52
New cards

Four mechanisms of antibiotic resistance

Permeability, Enzymes, Binding site changes, Efflux pumps. [extra] Mnemonic: BEEP = Binding site, Enzymes, Efflux, Permeability

53
New cards

Main resistance defense of GRAM POSITIVES

Binding site changes (altered target so the drug no longer fits). GPs have no outer membrane and no periplasmic space

54
New cards

Why do GRAM NEGATIVES have more resistance options?

Two membranes: outer-membrane porins can be altered or deleted (permeability), efflux pumps pump the drug out, and enzymes (beta-lactamases) wait in the periplasmic space (the "moat")

55
New cards

Why can't gram positives harbor beta-lactamases easily?

They have no periplasmic space to hold the enzymes

56
New cards

Intrinsic vs acquired resistance

Intrinsic = built in (e.g., drug too big/bulky to pass GN porins). Acquired = e.g., shared bacterial DNA encoding resistance

57
New cards

Beta-lactamase mechanism

Hydrolyzes the beta-lactam ring, so the antibiotic loses activity. Most common resistance mechanism to beta-lactams

58
New cards

How do we fight beta-lactamases?

Pair the beta-lactam with a beta-lactamase inhibitor (BLI)

59
New cards

Beta-lactamase Class A

Serine: penicillinases, cephalosporinases, ESBLs

60
New cards

Beta-lactamase Class B

Metallo-beta-lactamases: NOT inhibited by any BLIs (cefiderocol is active against MBLs)

61
New cards

Beta-lactamase Class C

AmpC: can be inhibited by next-generation BLIs

62
New cards

Beta-lactamase Class D

OXA-type (includes carbapenemases): can be inhibited by durlobactam

63
New cards

Which class of beta-lactamase is not inhibited by any BLI?

Class B (metallo-beta-lactamases)

64
New cards

AmpC organisms

HECK YES: Hafnia alvei, Enterobacter cloacae, Citrobacter freundii, Klebsiella aerogenes

65
New cards

AmpC: key resistance feature

INDUCIBLE. May look susceptible to 3rd-gen cephalosporins at first, then upregulates AmpC after a few days of therapy and becomes resistant

66
New cards

AmpC drug of choice

Cefepime (stable against AmpC)

67
New cards

ESBL organisms

E. coli, Klebsiella pneumoniae, Proteus mirabilis (all HNPEK members)

68
New cards

ESBL: what does it destroy?

Penicillins, 3rd-generation cephalosporins, monobactams

69
New cards

ESBL drug of choice

Carbapenem

70
New cards

Why is ceftriaxone a bad choice for Enterobacter, Citrobacter, K. aerogenes (HECK YES)?

AmpC is inducible and causes resistance to 3rd-gen cephalosporins. Use cefepime

71
New cards

Why does piperacillin/tazobactam NOT reliably cover Enterobacter/Citrobacter?

AmpC breaks down penicillins and tazobactam is a 1st-gen BLI that is poor at inhibiting AmpC

72
New cards

The S. aureus exception

S. aureus is the major GRAM-POSITIVE that makes beta-lactamase (penicillinase). Most beta-lactamases come from gram negatives

73
New cards

PSSA vs MSSA vs MRSA

PSSA = penicillin-susceptible (no penicillinase). MSSA = makes penicillinase but is susceptible to penicillinase-resistant penicillins (nafcillin, oxacillin). MRSA = has mecA gene, resistant to essentially all beta-lactams

74
New cards

MRSA resistance mechanism

mecA gene codes for PBP2a (altered PBP2), a BINDING SITE change; beta-lactams barely bind it

75
New cards

MSSA resistance mechanism

Penicillinase (an enzyme)

76
New cards

Beta-lactam classes (4)

Penicillins, Cephalosporins, Carbapenems, Monobactam

77
New cards

Beta-lactam mechanism of action

Inhibit bacterial cell wall synthesis by preventing peptidoglycan synthesis

78
New cards

Beta-lactam adverse effects

Hypersensitivity, GI upset, seizures (if drug accumulates, e.g., elderly with poor renal function not renally dosed), cytopenias with prolonged use, interstitial nephritis

79
New cards

Natural penicillins (agents)

Penicillin G (IV), Penicillin G benzathine (IM), Penicillin VK (PO)

80
New cards

Natural penicillin spectrum

Beta strep, Strep anginosus. If susceptible: Strep pneumo, viridans strep, E. faecalis. Covers GP mouth anaerobes. NO gram-negative coverage

81
New cards

Drug of choice for syphilis

Penicillin G benzathine (IM)

82
New cards

[extra] Group A strep pharyngitis: drug class to think of

Natural penicillin (Penicillin VK PO) or amoxicillin, since natural penicillins reliably cover beta-hemolytic strep. (Extends lecture; confirm guideline in rotation)

83
New cards

Aminopenicillins (agents)

Ampicillin (IV), Amoxicillin (PO)

84
New cards

Aminopenicillin spectrum

Beta strep, Strep anginosus, E. faecalis, N. meningitidis. If susceptible: H. flu, E. coli, Proteus

85
New cards

DOC for E. faecalis

Ampicillin (aminopenicillin; 1st line). [extra] Mnemonic: E. faecAlis = Ampicillin

86
New cards

Aminopenicillin + BLI (agents)

Ampicillin/sulbactam (IV), Amoxicillin/clavulanate (PO)

87
New cards

What does adding a BLI to an aminopenicillin add?

Better HNPEK coverage, plus MSSA and anaerobes. Still does NOT cover SPACE

88
New cards

Anti-staphylococcal penicillins (agents)

Nafcillin, oxacillin (IV); dicloxacillin (PO)

89
New cards

Anti-staphylococcal penicillin spectrum

MSSA, MS-CoNS, beta strep, Strep anginosus. NO gram-negative coverage

90
New cards

DOC (1st line) for MSSA and MS-CoNS

Anti-staphylococcal penicillins (nafcillin, oxacillin, dicloxacillin) or 1st-gen cephalosporin (cefazolin)

91
New cards

Piperacillin/tazobactam spectrum

MSSA, MS-CoNS, strep, E. faecalis, HNPEK, Serratia, Pseudomonas, anaerobes. Starts to cover SPACE (Serratia, Pseudomonas) but NOT Enterobacter/Citrobacter (AmpC)

92
New cards

Piperacillin comes only with...

Tazobactam. IV product only

93
New cards

Cephalosporin coverage trend as generation goes up

Gram-positive coverage goes DOWN and gram-negative coverage goes UP (1st gen = best GP; 3rd gen = most GN of the first three). 4th gen is the broadest (adds Pseudomonas and AmpC organisms)

94
New cards

[extra] How the HNPEK GN coverage builds across generations

1st gen = PEK; 2nd gen = H + PEK; 3rd gen (X group) = full HNPEK. Just add letters as the generation goes up

95
New cards

1st-gen cephalosporins (agents)

Cefazolin (IV); cephalexin, cefadroxil (PO)

96
New cards

1st-gen spectrum

MSSA, MS-CoNS, beta strep, Strep anginosus, plus PEK (Proteus, E. coli, Klebsiella)

97
New cards

Cefazolin is 1st line for...

MSSA and MS-CoNS

98
New cards

Targeted therapy example from lecture: susceptible E. coli UTI

Cefazolin (1st gen; covers PEK)

99
New cards

2nd-gen cephalosporins (agents)

Cefuroxime (IV and PO); cephamycins cefotetan and cefoxitin (IV)

100
New cards

2nd-gen spectrum

MSSA, CoNS, strep (a little more strep than 1st gen), H. flu, PEK. Cephamycins ALSO cover anaerobes